251 related articles for article (PubMed ID: 23279867)
1. Synthesis and biological activity against Trypanosoma cruzi of substituted 1,4-naphthoquinones.
Olímpio da Silva A; da Silva Lopes R; Vieira de Lima R; Santos Suniga Tozatti C; Marques MR; de Albuquerque S; Beatriz A; Pires de Lima D
Eur J Med Chem; 2013 Feb; 60():51-6. PubMed ID: 23279867
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones.
da Silva Júnior EN; de Souza MC; Fernandes MC; Menna-Barreto RF; Pinto Mdo C; de Assis Lopes F; de Simone CA; Andrade CK; Pinto AV; Ferreira VF; de Castro SL
Bioorg Med Chem; 2008 May; 16(9):5030-8. PubMed ID: 18378461
[TBL] [Abstract][Full Text] [Related]
3. On the search for potential anti-Trypanosoma cruzi drugs: synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions.
da Silva Júnior EN; de Melo IM; Diogo EB; Costa VA; de Souza Filho JD; Valença WO; Camara CA; de Oliveira RN; de Araujo AS; Emery FS; dos Santos MR; de Simone CA; Menna-Barreto RF; de Castro SL
Eur J Med Chem; 2012 Jun; 52():304-12. PubMed ID: 22483633
[TBL] [Abstract][Full Text] [Related]
4. New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms.
Carneiro PF; do Nascimento SB; Pinto AV; Pinto Mdo C; Lechuga GC; Santos DO; dos Santos Júnior HM; Resende JA; Bourguignon SC; Ferreira VF
Bioorg Med Chem; 2012 Aug; 20(16):4995-5000. PubMed ID: 22795899
[TBL] [Abstract][Full Text] [Related]
5. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
[TBL] [Abstract][Full Text] [Related]
6. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV
Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742
[TBL] [Abstract][Full Text] [Related]
7. Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi.
Salmon-Chemin L; Lemaire A; De Freitas S; Deprez B; Sergheraert C; Davioud-Charvet E
Bioorg Med Chem Lett; 2000 Apr; 10(7):631-5. PubMed ID: 10762041
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a small library of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives bearing anti-trypanosomal and anti-leishmanial activity.
Bolognesi ML; Lizzi F; Perozzo R; Brun R; Cavalli A
Bioorg Med Chem Lett; 2008 Apr; 18(7):2272-6. PubMed ID: 18353643
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids.
Coa JC; Castrillón W; Cardona W; Carda M; Ospina V; Muñoz JA; Vélez ID; Robledo SM
Eur J Med Chem; 2015 Aug; 101():746-53. PubMed ID: 26218652
[TBL] [Abstract][Full Text] [Related]
10. Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice.
dos Santos Filho JM; Moreira DR; de Simone CA; Ferreira RS; McKerrow JH; Meira CS; Guimarães ET; Soares MB
Bioorg Med Chem; 2012 Nov; 20(21):6423-33. PubMed ID: 23006639
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.
Tempone AG; Ferreira DD; Lima ML; Costa Silva TA; Borborema SET; Reimão JQ; Galuppo MK; Guerra JM; Russell AJ; Wynne GM; Lai RYL; Cadelis MM; Copp BR
Eur J Med Chem; 2017 Oct; 139():947-960. PubMed ID: 28881289
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antiprotozoal and cytotoxic activities of new N-(3,4-dimethyl-5-isoxazolyl)-1,2-naphthoquinone-4-amino derivatives.
Sperandeo NR; Briñón MC; Brun R
Farmaco; 2004 Jun; 59(6):431-5. PubMed ID: 15178304
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
Aponte JC; Verástegui M; Málaga E; Zimic M; Quiliano M; Vaisberg AJ; Gilman RH; Hammond GB
J Med Chem; 2008 Oct; 51(19):6230-4. PubMed ID: 18798609
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of pyrazolylnaphthoquinones as new potential antiprotozoal and cytotoxic agents.
Sperandeo NR; Brun R
Chembiochem; 2003 Jan; 4(1):69-72. PubMed ID: 12512078
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, trypanocidal and anti-leishmania activity of new triazole-lapachol and nor-lapachol hybrids.
Pertino MW; F de la Torre A; Schmeda-Hirschmann G; Vega C; Rolón M; Coronel C; Rojas de Arias A; Leal López K; Carranza-Rosales P; Viveros Valdez E
Bioorg Chem; 2020 Oct; 103():104122. PubMed ID: 32745754
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis.
Ravaschino EL; Docampo R; Rodriguez JB
J Med Chem; 2006 Jan; 49(1):426-35. PubMed ID: 16392828
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and identification of novel molecular hybrids based on naphthoquinone aromatic hydrazides as potential trypanocide and leishmanicidal agents.
Cezar RD; Silva AOD; Lopes RS; Nakamura CV; Rodrigues JHS; Lourenço EMG; Saba S; Beatriz A; Rafique J; Lima DP
An Acad Bras Cienc; 2024; 96(2):e20230375. PubMed ID: 38747836
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of naphthofuranquinones with activity against Trypanosoma cruzi.
Silva RS; Costa EM; Trindade UL; Teixeira DV; Pinto Mde C; Santos GL; Malta VR; De Simone CA; Pinto AV; de Castro SL
Eur J Med Chem; 2006 Apr; 41(4):526-30. PubMed ID: 16500733
[TBL] [Abstract][Full Text] [Related]
20. Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies.
Sharma G; Chowdhury S; Sinha S; Majumder HK; Kumar SV
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):185-9. PubMed ID: 23534930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
